Literature DB >> 274940

Hypertension due to a renin-secreting tumour localised by segmental renal vein sampling.

J M Bonnin, M D Cain, J S Jose, T M Mukherjee, L V Perrett, G C Scroop, A E Seymour.   

Abstract

An 18-year-old female was found to be hypertensive on routine medical examination. Further investigation disclosed persistent hypokalaemia and elevated plasma renin activity in peripheral venous blood. Segmental renal vein sampling with assay of blood samples located the source of excess renin secretion in the lower mid-zone of the left kidney. This localization was not confirmed by either angiography or by palpation of the exposed kidney before nephrectomy but macroscopic examination of the freshly sectioned kidney revealed a small tumour in the region suggested by renal vein sampling. The tumour had the morphologic pattern fo an haemangiopericytoma with abundant ultrastructural specific granules and very high renin activity by tissue assay. Plasma renin activity fell precipitously after nephrectomy and remained very low for the first week. Although the immediate post-operative blood pressure fell to normal, hypertension recurred temporarily and was associated with elevated plasma aldosteron, producing a syndrome similar to primary aldosteronism. All variables returned to normal without specific therapy and hypertension has not subsequently recurred.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 274940     DOI: 10.1111/j.1445-5994.1977.tb02320.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  2 in total

1.  Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.

Authors:  J P Chalmers; L M Wing; J J Grygiel; M J West; J R Graham; A J Bune
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 2.  Hypertension secondary to renin-secreting juxtaglomerular cell tumor: case report and review of 38 cases.

Authors:  M McVicar; C Carman; M Chandra; R J Abbi; S Teichberg; E Kahn
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.